Opioid Prescription Verification Act of 2021

Bill: 117-hr-2355
Sponsor: full_name: Rep. Davis, Rodney [R-IL-13]
Introduced: 2021-04-05
Policy area: Health
Subjects: Business records

Drug trafficking and controlled substances

Drug, alcohol, tobacco use

Government information and archives

Health information and medical records

Health personnel

Health programs administration and funding

Photography and imaging

Prescription drugs

Retail and wholesale trades
Latest action: action_date: 2021-12-09
text: Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Summaries:
action_date: 2021-04-05
action_desc: Introduced in House
text: <p><strong>Opioid Prescription Verification Act of 2021</strong></p> <p>This bill modifies overdose prevention activities carried out by the Department of Health and Human Services (HHS) and the Centers for Disease Control and Prevention (CDC).</p> <p>Specifically, HHS must update pharmacist training materials to include information about how to verify the identity of individuals who pick up prescribed medications.</p> <p>In addition, the CDC may give preference, in awarding grants for overdose prevention, to states that</p> <ul> <li>maintain a prescription drug monitoring program that mandates the collection of specified information, and </li> <li>require dispensers of certain potentially addictive drugs to verify the identity of individuals who pick up prescribed medications. </li> </ul>

action_date: 2021-11-30
action_desc: Reported to House
text: <p><strong>Opioid Prescription Verification Act of 2021</strong></p> <p>This bill modifies overdose prevention activities carried out by the Department of Health and Human Services (HHS) and the Centers for Disease Control and Prevention (CDC).</p> <p>Specifically, HHS must update pharmacist training materials to include information about how to verify the identity of patients who are prescribed medications.</p> <p>In addition, the CDC may give preference, in awarding grants for overdose prevention, to states that</p> <ul> <li>maintain a prescription drug monitoring program that mandates the collection of specified information,</li> <li>require prescribers of certain potentially addictive medications to issue prescriptions electronically (subject to some exceptions), and</li> <li>require dispensers of certain potentially addictive medications to enter particular information about the purchase of such medications into their state's prescription drug monitoring program.</li> </ul>

action_date: 2021-12-08
action_desc: Passed House
text: <p><strong>Opioid Prescription Verification Act of 2021</strong></p> <p>This bill modifies overdose prevention activities carried out by the Department of Health and Human Services (HHS) and the Centers for Disease Control and Prevention (CDC).</p> <p>Specifically, HHS must update pharmacist training materials to include information about how to verify the identity of patients who are prescribed medications.</p> <p>In addition, the CDC may give preference, in awarding grants for overdose prevention, to states that</p> <ul> <li>maintain a prescription drug monitoring program that mandates the collection of specified information,</li> <li>require prescribers of certain potentially addictive medications to issue prescriptions electronically (subject to some exceptions), and</li> <li>require dispensers of certain potentially addictive medications to enter particular information about the purchase of such medications into their state's prescription drug monitoring program.</li> </ul>

tv_txt: I 117th CONGRESS 1st Session H. R. 2355 IN THE HOUSE OF REPRESENTATIVES April 5, 2021 Mr. Rodney Davis of Illinois (for himself, Mr. Bilirakis , and Mrs. Wagner ) introduced the following bill; which was referred to the Committee on Energy and Commerce A BILL To facilitate responsible, informed dispensing of controlled substances and other prescribed medications, and for other purposes.

1. Short title This Act may be cited as the Opioid Prescription Verification Act of 2021 . 2. Materials for training pharmacists on certain circumstances under which a pharmacist may decline to fill a prescription (a) Updates to materials Section 3212(a) of the SUPPORT for Patients and Communities Act ( Public Law 115–271 ) is amended by striking Not later than 1 year after the date of enactment of this Act, the Secretary of Health and Human Services, in consultation with the Administrator of the Drug Enforcement Administration, Commissioner of Food and Drugs, Director of the Centers for Disease Control and Prevention, and Assistant Secretary for Mental Health and Substance Use, shall develop and disseminate and inserting The Secretary of Health and Human Services, in consultation with the Administrator of the Drug Enforcement Administration, Commissioner of Food and Drugs, Director of the Centers for Disease Control and Prevention, and Assistant Secretary for Mental Health and Substance Use, shall develop and disseminate not later than 1 year after the date of enactment of this Act, and update periodically thereafter . (b) Materials included Section 3212(b) of the SUPPORT for Patients and Communities Act ( Public Law 115–271 ) is amended— (1) by redesignating paragraphs (1) and (2) as paragraphs (2) and (3), respectively; and (2) by inserting before paragraph (2), as so redesignated, the following new paragraph: (1) pharmacists on how to verify the identity of individuals picking up prescriptions; . (c) Materials for training on verification of identity Section 3212 of the SUPPORT for Patients and Communities Act ( Public Law 115–271 ) is amended by adding at the end the following new subsection: (d) Materials for training on verification of identity of individuals picking up prescribed medications Not later than 6 months after the date of enactment of this subsection, the Secretary of Health and Human Services, after seeking stakeholder input in accordance with subsection (c), shall— (1) update the materials developed under subsection (a) to include information for pharmacists on how to verify the identity of individuals picking up prescribed medications; and (2) disseminate, as appropriate, the updated materials. . 3. Incentivizing States To facilitate responsible, informed dispensing of controlled substances (a) In general Section 392A of the Public Health Service Act ( 42 U.S.C. 280b–1 ) is amended— (1) by redesignating subsections (c) and (d) as subsections (d) and (e), respectively; and (2) by inserting after subsection (b) the following new subsection: (c) Preference In determining the amounts of grants awarded to States under subsections (a) and (b), the Director of the Centers for Disease Control and Prevention may give preference to States in accordance with such criteria as the Director may specify and may choose to give preference to States that— (1) maintain a prescription drug monitoring program; (2) require dispensers of controlled substances in schedule II, III, or IV to verify the identity of the person who picks up a prescribed medication by requiring such person to present a photo identification card that is valid as determined by the respective State; and (3) require dispensers of such controlled substances to enter certain information about the purchase of such controlled substances into the respective State’s prescription drug monitoring program, including— (A) the National Drug Code or, in the case of compounded medications, compound identifier; (B) the quantity dispensed; (C) the name of the patient; (D) the name of the ultimate user; (E) the name of the person who picks up the controlled substance, if different from the patient and ultimate user; and (F) the date filled. . (b) Definitions Subsection (d) of section 392A of the Public Health Service Act ( 42 U.S.C. 280b–1 ), as redesignated by subsection (a)(1), is amended to read as follows: (d) Definitions In this section: (1) Controlled substance The term controlled substance has the meaning given that term in section 102 of the Controlled Substances. (2) Dispenser The term dispenser means a physician, pharmacist, or other person that dispenses a controlled substance to an ultimate user. (3) Indian tribe The term Indian tribe has the meaning given that term in section 4 of the Indian Self-Determination and Education Assistance Act. (4) State The term State means each of the 50 States, the District of Columbia, and any commonwealth or territory of the United States. (5) Ultimate user The term ultimate user means a person who has obtained from a dispenser, and who possesses, a controlled substance for the person’s own use, for the use of a member of the person’s household, or for the use of an animal. .

tv_txt: IB Union Calendar No. 130 117th CONGRESS 1st Session H. R. 2355 [Report No. 117–180] IN THE HOUSE OF REPRESENTATIVES April 5, 2021 Mr. Rodney Davis of Illinois (for himself, Mr. Bilirakis , and Mrs. Wagner ) introduced the following bill; which was referred to the Committee on Energy and Commerce November 30, 2021 Additional sponsors: Mr. Turner , Mr. Kinzinger , Mr. Mooney , Mr. C. Scott Franklin of Florida , Mr. LaMalfa , and Mr. Budd November 30, 2021 Reported with an amendment; committed to the Committee of the Whole House on the State of the Union and ordered to be printed Strike out all after the enacting clause and insert the part printed in italic For text of introduced bill, see copy of bill as introduced on April 5, 2021 A BILL To facilitate responsible, informed dispensing of controlled substances and other prescribed medications, and for other purposes.

1. Short title This Act may be cited as the Opioid Prescription Verification Act of 2021 . 2. Materials for training pharmacists on certain circumstances under which a pharmacist may decline to fill a prescription (a) Updates to materials Section 3212(a) of the SUPPORT for Patients and Communities Act ( 21 U.S.C. 829 note) is amended by striking Not later than 1 year after the date of enactment of this Act, the Secretary of Health and Human Services, in consultation with the Administrator of the Drug Enforcement Administration, Commissioner of Food and Drugs, Director of the Centers for Disease Control and Prevention, and Assistant Secretary for Mental Health and Substance Use, shall develop and disseminate and inserting The Secretary of Health and Human Services, in consultation with the Administrator of the Drug Enforcement Administration, Commissioner of Food and Drugs, Director of the Centers for Disease Control and Prevention, and Assistant Secretary for Mental Health and Substance Use, shall develop and disseminate not later than 1 year after the date of enactment of this Act, and update periodically thereafter . (b) Materials included Section 3212(b) of the SUPPORT for Patients and Communities Act ( 21 U.S.C. 829 note) is amended— (1) by redesignating paragraphs (1) and (2) as paragraphs (2) and (3), respectively; and (2) by inserting before paragraph (2), as so redesignated, the following new paragraph: (1) pharmacists on how to verify the identity of the patient; . (c) Materials for training on patient verification Section 3212 of the SUPPORT for Patients and Communities Act ( 21 U.S.C. 829 note) is amended by adding at the end the following new subsection: (d) Materials for training on verification of identity Not later than 1 year after the date of enactment of this subsection, the Secretary of Health and Human Services, after seeking stakeholder input in accordance with subsection (c), shall— (1) update the materials developed under subsection (a) to include information for pharmacists on how to verify the identity the patient; and (2) disseminate, as appropriate, the updated materials. . 3. Incentivizing States To facilitate responsible, informed dispensing of controlled substances (a) In general Section 392A of the Public Health Service Act ( 42 U.S.C. 280b–1 ) is amended— (1) by redesignating subsections (c) and (d) as subsections (d) and (e), respectively; and (2) by inserting after subsection (b) the following new subsection: (c) Preference In determining the amounts of grants awarded to States under subsections (a) and (b), the Director of the Centers for Disease Control and Prevention may give preference to States in accordance with such criteria as the Director may specify and may choose to give preference to States that— (1) maintain a prescription drug monitoring program; (2) require prescribers of controlled substances in schedule II, III, or IV to issue such prescriptions electronically, and make such requirement subject to exceptions in the cases listed in section 1860D–4(e)(7)(B) of the Social Security Act; and (3) require dispensers of such controlled substances to enter certain information about the purchase of such controlled substances into the respective State’s prescription drug monitoring program, including— (A) the National Drug Code or, in the case of compounded medications, compound identifier; (B) the quantity dispensed; (C) the patient identifier; and (D) the date filled. . (b) Definitions Subsection (d) of section 392A of the Public Health Service Act ( 42 U.S.C. 280b–1 ), as redesignated by subsection (a)(1), is amended to read as follows: (d) Definitions In this section: (1) Controlled substance The term controlled substance has the meaning given that term in section 102 of the Controlled Substances Act. (2) Dispenser The term dispenser means a physician, pharmacist, or other person that dispenses a controlled substance to an ultimate user. (3) Indian tribe The term Indian tribe has the meaning given that term in section 4 of the Indian Self-Determination and Education Assistance Act. .

November 30, 2021 Reported with an amendment; committed to the Committee of the Whole House on the State of the Union and ordered to be printed

tv_txt: I 117th CONGRESS 1st Session H. R. 2355 IN THE HOUSE OF REPRESENTATIVES AN ACT To facilitate responsible, informed dispensing of controlled substances and other prescribed medications, and for other purposes.

1. Short title This Act may be cited as the Opioid Prescription Verification Act of 2021 . 2. Materials for training pharmacists on certain circumstances under which a pharmacist may decline to fill a prescription (a) Updates to materials Section 3212(a) of the SUPPORT for Patients and Communities Act ( 21 U.S.C. 829 note) is amended by striking Not later than 1 year after the date of enactment of this Act, the Secretary of Health and Human Services, in consultation with the Administrator of the Drug Enforcement Administration, Commissioner of Food and Drugs, Director of the Centers for Disease Control and Prevention, and Assistant Secretary for Mental Health and Substance Use, shall develop and disseminate and inserting The Secretary of Health and Human Services, in consultation with the Administrator of the Drug Enforcement Administration, Commissioner of Food and Drugs, Director of the Centers for Disease Control and Prevention, and Assistant Secretary for Mental Health and Substance Use, shall develop and disseminate not later than 1 year after the date of enactment of this Act, and update periodically thereafter . (b) Materials included Section 3212(b) of the SUPPORT for Patients and Communities Act ( 21 U.S.C. 829 note) is amended— (1) by redesignating paragraphs (1) and (2) as paragraphs (2) and (3), respectively; and (2) by inserting before paragraph (2), as so redesignated, the following new paragraph: (1) pharmacists on how to verify the identity of the patient; . (c) Materials for training on patient verification Section 3212 of the SUPPORT for Patients and Communities Act ( 21 U.S.C. 829 note) is amended by adding at the end the following new subsection: (d) Materials for training on verification of identity Not later than 1 year after the date of enactment of this subsection, the Secretary of Health and Human Services, after seeking stakeholder input in accordance with subsection (c), shall— (1) update the materials developed under subsection (a) to include information for pharmacists on how to verify the identity the patient; and (2) disseminate, as appropriate, the updated materials. . 3. Incentivizing States To facilitate responsible, informed dispensing of controlled substances (a) In general Section 392A of the Public Health Service Act ( 42 U.S.C. 280b–1 ) is amended— (1) by redesignating subsections (c) and (d) as subsections (d) and (e), respectively; and (2) by inserting after subsection (b) the following new subsection: (c) Preference In determining the amounts of grants awarded to States under subsections (a) and (b), the Director of the Centers for Disease Control and Prevention may give preference to States in accordance with such criteria as the Director may specify and may choose to give preference to States that— (1) maintain a prescription drug monitoring program; (2) require prescribers of controlled substances in schedule II, III, or IV to issue such prescriptions electronically, and make such requirement subject to exceptions in the cases listed in section 1860D–4(e)(7)(B) of the Social Security Act; and (3) require dispensers of such controlled substances to enter certain information about the purchase of such controlled substances into the respective State’s prescription drug monitoring program, including— (A) the National Drug Code or, in the case of compounded medications, compound identifier; (B) the quantity dispensed; (C) the patient identifier; and (D) the date filled. . (b) Definitions Subsection (d) of section 392A of the Public Health Service Act ( 42 U.S.C. 280b–1 ), as redesignated by subsection (a)(1), is amended to read as follows: (d) Definitions In this section: (1) Controlled substance The term controlled substance has the meaning given that term in section 102 of the Controlled Substances Act. (2) Dispenser The term dispenser means a physician, pharmacist, or other person that dispenses a controlled substance to an ultimate user. (3) Indian tribe The term Indian tribe has the meaning given that term in section 4 of the Indian Self-Determination and Education Assistance Act. .

Passed the House of Representatives December 8, 2021. Cheryl L. Johnson, Clerk.

tv_txt: IIB 117th CONGRESS 1st Session H. R. 2355 IN THE SENATE OF THE UNITED STATES December 9, 2021 Received; read twice and referred to the Committee on Health, Education, Labor, and Pensions AN ACT To facilitate responsible, informed dispensing of controlled substances and other prescribed medications, and for other purposes.

1. Short title This Act may be cited as the Opioid Prescription Verification Act of 2021 . 2. Materials for training pharmacists on certain circumstances under which a pharmacist may decline to fill a prescription (a) Updates to materials Section 3212(a) of the SUPPORT for Patients and Communities Act ( 21 U.S.C. 829 note) is amended by striking Not later than 1 year after the date of enactment of this Act, the Secretary of Health and Human Services, in consultation with the Administrator of the Drug Enforcement Administration, Commissioner of Food and Drugs, Director of the Centers for Disease Control and Prevention, and Assistant Secretary for Mental Health and Substance Use, shall develop and disseminate and inserting The Secretary of Health and Human Services, in consultation with the Administrator of the Drug Enforcement Administration, Commissioner of Food and Drugs, Director of the Centers for Disease Control and Prevention, and Assistant Secretary for Mental Health and Substance Use, shall develop and disseminate not later than 1 year after the date of enactment of this Act, and update periodically thereafter . (b) Materials included Section 3212(b) of the SUPPORT for Patients and Communities Act ( 21 U.S.C. 829 note) is amended— (1) by redesignating paragraphs (1) and (2) as paragraphs (2) and (3), respectively; and (2) by inserting before paragraph (2), as so redesignated, the following new paragraph: (1) pharmacists on how to verify the identity of the patient; . (c) Materials for training on patient verification Section 3212 of the SUPPORT for Patients and Communities Act ( 21 U.S.C. 829 note) is amended by adding at the end the following new subsection: (d) Materials for training on verification of identity Not later than 1 year after the date of enactment of this subsection, the Secretary of Health and Human Services, after seeking stakeholder input in accordance with subsection (c), shall— (1) update the materials developed under subsection (a) to include information for pharmacists on how to verify the identity the patient; and (2) disseminate, as appropriate, the updated materials. . 3. Incentivizing States To facilitate responsible, informed dispensing of controlled substances (a) In general Section 392A of the Public Health Service Act ( 42 U.S.C. 280b–1 ) is amended— (1) by redesignating subsections (c) and (d) as subsections (d) and (e), respectively; and (2) by inserting after subsection (b) the following new subsection: (c) Preference In determining the amounts of grants awarded to States under subsections (a) and (b), the Director of the Centers for Disease Control and Prevention may give preference to States in accordance with such criteria as the Director may specify and may choose to give preference to States that— (1) maintain a prescription drug monitoring program; (2) require prescribers of controlled substances in schedule II, III, or IV to issue such prescriptions electronically, and make such requirement subject to exceptions in the cases listed in section 1860D–4(e)(7)(B) of the Social Security Act; and (3) require dispensers of such controlled substances to enter certain information about the purchase of such controlled substances into the respective State’s prescription drug monitoring program, including— (A) the National Drug Code or, in the case of compounded medications, compound identifier; (B) the quantity dispensed; (C) the patient identifier; and (D) the date filled. . (b) Definitions Subsection (d) of section 392A of the Public Health Service Act ( 42 U.S.C. 280b–1 ), as redesignated by subsection (a)(1), is amended to read as follows: (d) Definitions In this section: (1) Controlled substance The term controlled substance has the meaning given that term in section 102 of the Controlled Substances Act. (2) Dispenser The term dispenser means a physician, pharmacist, or other person that dispenses a controlled substance to an ultimate user. (3) Indian tribe The term Indian tribe has the meaning given that term in section 4 of the Indian Self-Determination and Education Assistance Act. .

Passed the House of Representatives December 8, 2021. Cheryl L. Johnson, Clerk.